OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy
Jiang Chen, Zohreh Amoozgar, Xin Liu, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 4, pp. 400-412
Open Access | Times Cited: 8
Jiang Chen, Zohreh Amoozgar, Xin Liu, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 4, pp. 400-412
Open Access | Times Cited: 8
Showing 8 citing articles:
Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma
Fei Chen, Jian Sheng, Xiaoping Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116659-116659
Open Access | Times Cited: 4
Fei Chen, Jian Sheng, Xiaoping Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116659-116659
Open Access | Times Cited: 4
The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy
Guandu Li, Xiangyu Che, Shijin Wang, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Guandu Li, Xiangyu Che, Shijin Wang, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies
Jian‐Yang Ao, Mingtai Hu, Jinghan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Jian‐Yang Ao, Mingtai Hu, Jinghan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine
Takafumi Mie, Takashi Sasaki, Takeshi Okamoto, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 879-879
Open Access | Times Cited: 3
Takafumi Mie, Takashi Sasaki, Takeshi Okamoto, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 879-879
Open Access | Times Cited: 3
Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer
Luohang Ni, Jianing Xu, Quanpeng Li, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 941-963
Open Access | Times Cited: 1
Luohang Ni, Jianing Xu, Quanpeng Li, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 941-963
Open Access | Times Cited: 1
Targeting cancer-associated fibroblasts/tumor cells cross-talk inhibits intrahepatic cholangiocarcinoma progression via cell-cycle arrest
Serena Mancarella, Isabella Gigante, Elena Antinoro Pizzuto, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Serena Mancarella, Isabella Gigante, Elena Antinoro Pizzuto, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Emerging biomarkers for immunotherapy response in biliary tract cancers: a comprehensive review of immune checkpoint inhibitor strategies
Yidan Lou, Yijing Chen, Kaibo Guo, et al.
Biomarkers in Medicine (2024) Vol. 18, Iss. 15-16, pp. 703-715
Closed Access
Yidan Lou, Yijing Chen, Kaibo Guo, et al.
Biomarkers in Medicine (2024) Vol. 18, Iss. 15-16, pp. 703-715
Closed Access
Intra- and Extrahepatic Cholangiocarcinomas Display Differing Sensitivities to NK Cell Lysis and Modulate NK Cell Function Through Shared and Distinct Pathways
Ian C. Henrich, Ngan Nguyen
Molecular Cancer Research (2024) Vol. 23, Iss. 2, pp. 155-168
Closed Access
Ian C. Henrich, Ngan Nguyen
Molecular Cancer Research (2024) Vol. 23, Iss. 2, pp. 155-168
Closed Access
